Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
8.61
-0.12 (-1.37%)
At close: Jun 18, 2025, 4:00 PM
8.87
+0.26 (3.02%)
After-hours: Jun 18, 2025, 7:39 PM EDT

Nektar Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover Nektar Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $4.92, which forecasts a -42.86% decrease in the stock price over the next year. The lowest target is $2 and the highest is $7.

Price Target: $4.92 (-42.86%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $2.00 $4.92 $6.00 $7.00
Change -76.77% -42.86% -30.31% -18.70%
* Price targets were last updated on Apr 11, 2025.

Analyst Ratings

The average analyst rating for Nektar Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 333444
Buy 112222
Hold 110000
Sell 000000
Strong Sell 000000
Total 555666

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Jefferies
Jefferies
Strong Buy
Upgrades
$1$2
Strong Buy Upgrades $1$2 -76.77% Apr 11, 2025
Oppenheimer
Oppenheimer
Buy
Upgrades
$6
Buy Upgrades $6 -30.31% Mar 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6.5
Strong Buy Reiterates $6.5 -24.51% Mar 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6.5
Strong Buy Reiterates $6.5 -24.51% Feb 25, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6.5
Strong Buy Reiterates $6.5 -24.51% Jan 13, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
44.40M
from 98.43M
Decreased by -54.89%
Revenue Next Year
40.71M
from 44.40M
Decreased by -8.31%
EPS This Year
-0.79
from -8.68
EPS Next Year
-0.84
from -0.79
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
152.92M101.91M92.06M90.12M98.43M44.40M40.71M33.93M
Revenue Growth
33.41%-33.36%-9.67%-2.10%9.22%-54.89%-8.31%-16.67%
EPS
-37.33-42.90-29.55-21.79-8.68-0.79-0.84-0.94
EPS Growth
--------
Forward PE
--------
No. Analysts
-----10109
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 50.5M54.6M54.6M
Avg 44.4M40.7M33.9M
Low 39.2M23.5M7.9M

Revenue Growth

Revenue Growth 20252026202720282029
High
-48.7%
23.0%
34.1%
Avg
-54.9%
-8.3%
-16.7%
Low
-60.2%
-47.0%
-80.5%

EPS Forecast

EPS 20252026202720282029
High -0.64-0.55-0.39
Avg -0.79-0.84-0.94
Low -0.95-1.32-1.86

EPS Growth

EPS Growth 20252026202720282029
High ---
Avg ---
Low ---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.